PF4 and COVID-19: Platelet factor 4 (PF4) and platelet-expressing chemokines pro-platelet basic protein (PPBP) were reported significantly downregulated in severe COVID-19 patients, which associated with platelet degranulation and potently contributed to thrombopenia (5).